Jananese Society of Hypertension (JSH) Guidelines for Self-Monitoring of Blood Pressure at Home

Imai, Yutaka; Otsuka, Kuniaki; Kawano, Yuhei; Shimada, Kazuyuki; Hayashi, Hiroshi; Tochikubo, Osamu; Miyakawa, Masaaki; Fukiyama, Koshiro

doi:10.1291/hypres.26.771

Cited by 295 publications

(288 citation statements)

References 31 publications

Supporting

Mentioning

282

Contrasting

Unclassified

Order By: Relevance

“…Despite common ownership of a home sphygmomanometer, daily practice of HBPM in Turkey was far from the recommendations of the current guidelines. [2][3][4]18 In spite of common ownership of a home sphygmomanometer, the regular measurement of BP by a small group of patients, before visits with their physicians, indicated ineffective BP measurement at home. We suspect that the main findings of the current study, namely, the lack of training by health-care professionals and the dominance of wrist devices, would also be found in other developing and underdeveloped countries.…”

Section: Discussionmentioning

confidence: 99%

Use of home sphygmomanometers in Turkey: a nation-wide survey

et al. 2011

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Use of home sphygmomanometers in Turkey: a nation-wide survey

et al. 2011

View full text Add to dashboard Cite

“…Measurements of morning BP were made within 1 h of waking, before breakfast or taking any drugs, with the patient seated and rested for at least 5 min. 9 Measurements of evening BP were obtained in a homologous way just before going to bed. The cuff was placed directly around their non-dominant arm and the position of cuff was maintained at the level of the heart.…”

Section: Coefficient Of Variationmentioning

confidence: 99%

“…We calculated the standard deviation (s.d.) of HBP for all 14 days, for the first half (measured during days 1-7) and for the latter half (measured during days [8][9][10][11][12][13][14] in the morning and in the evening. As an indicator for variability in BP, we defined the CV of HBP as s.d.…”

Section: Coefficient Of Variationmentioning

confidence: 99%

The coefficient variation of home blood pressure is a novel factor associated with macroalbuminuria in type 2 diabetes mellitus

et al. 2011

View full text Add to dashboard Cite

The purpose of this study was to investigate the association between day-by-day variability in home blood pressure (HBP) on 14 consecutive days and macroalbuminuria in patients with type 2 diabetes. We compared the coefficient of variation (CV) of HBP in 858 Japanese patients with and without macroalbuminuria. Next, we analyzed the relationship between the logarithm of urinary albumin excretion (UAE) and the CV of HBP using linear regression analysis. Then, we evaluated the association between the CV of HBP and macroalbuminuria, defined as UAE X300 mg g À1 creatinine, using logistic regression analysis. The CVs of morning and evening systolic blood pressure (SBP) were significantly greater in patients with macroalbuminuria than in those without (8.08±3.35 vs. 7.19±2.25%, Po0.05 and 9.01±3.58 vs. 7.98±2.57%, Po0.05, respectively). Multivariate linear regression analyses indicated that the CVs of morning SBP (Po0.05) and diastolic blood pressure (DBP; Po0.05), and those of evening SBP (Po0.05) were the independent explanatory variables for the logarithm of UAE. Multivariate logistic regression analyses also demonstrated that the odds ratio for the CVs of morning SBP, morning DBP and evening SBP for macroalbuminuria were 1.35 (Po0.05), 1.29 (Po0.05) and 1.44 (Po0.05), respectively. We conclude that the CV of HBP is correlated with macroalbuminuria, independent of the known risk factors, in Japanese patients with type 2 diabetes.

show abstract

“…16 The measurements obtained while the patient was in the standing position were performed in the same manner at home and in the clinic.…”

Section: Bp Measurementsmentioning

confidence: 99%

Orthostatic hypertension: home blood pressure monitoring for detection and assessment of treatment with doxazosin

et al. 2011

View full text Add to dashboard Cite

To determine the role of home blood pressure (BP) monitoring for a reproducible assessment of orthostatic hypertension (OHT) and the effectiveness of hypertension control by doxazosin. In this study, 605 medicated hypertensive outpatients were enrolled. Home BP in the sitting and standing positions was monitored in all patients in the morning and evening for 6 months. According to an open-label multicenter trial design, the patients were randomly allocated to either an intervention group that took doxazosin (1-4 mg) at bedtime or to a control group that did not receive any add-on medication. The patients were divided into deciles of orthostatic BP change as evaluated by home BP monitoring at baseline. Those in the top decile, in the lowest decile and in deciles two through eight were then assigned to the OHT group, the orthostatic hypotension group and the orthostatic normotension group, respectively.Orthostatic BP in the OHYPO group did not change, whereas that of the OHT group was markedly reduced by doxazosin (Po0.01). In the control group, classification into orthostatic BP categories using home BP monitoring was more reproducible (j coefficient: 0.42-0.50) than when using clinical BP (j coefficient: 0.13-0.24). In all groups, a reduction in the urinary albumin/creatinine ratio was significantly associated with a reduction in orthostatic BP doxazosin (Po0.001).The identification of OHT based on home BP monitoring was highly reproducible. The administration of doxazosin might control OHT and consequently prevent target organ damage.

show abstract

Jananese Society of Hypertension (JSH) Guidelines for Self-Monitoring of Blood Pressure at Home

Cited by 295 publications

References 31 publications

Use of home sphygmomanometers in Turkey: a nation-wide survey

Use of home sphygmomanometers in Turkey: a nation-wide survey

The coefficient variation of home blood pressure is a novel factor associated with macroalbuminuria in type 2 diabetes mellitus

Orthostatic hypertension: home blood pressure monitoring for detection and assessment of treatment with doxazosin

Contact Info

Product

Resources

About